Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

  • Patients treated with drugs targeting the epidermal growth factor receptor (EGFR) frequently develop acneiform skin toxicities. These skin reactions can impair treatment adherence and clinical outcome. Prophylactic treatment with doxycycline reduces the severity of skin toxicities. ...

Download full text files

Export metadata

Metadaten
Author:Maria Gaiser, Sylvie Lorenzen, Kirsten Merx, Jörg TrojanORCiDGND, Janja Ocvirk, Thomas Jens Ettrich, Salah-Eddin al- BatranORCiDGND, Holger Schulz, Nils Homann, Hans-Peter Feustel, Michael Schatz, Melanie Kripp, Nadine Schulte, Steffen Heeger, Soetkin Vlassak, Winfried Koch, Ralf-Dieter HofheinzORCiDGND
URN:urn:nbn:de:hebis:30:3-535658
DOI:https://doi.org/10.1093/annonc/mdy451
ISSN:1569-8041
ISSN:0923-7534
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/30307464
Parent Title (English):Annals of oncology
Publisher:Oxford Univ. Press
Place of publication:Oxford
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/10/11
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2020/05/20
Volume:29
Issue:12
Page Number:3
First Page:2393
Last Page:2395
Note:
User License: Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
HeBIS-PPN:465004032
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung-Nicht kommerziell - Keine Bearbeitung 4.0

OPUS4 Logo